However there are concerns the process has been rushed.
President Putin says one of his daughters has already had it, and it's undergone proper testing.
But scientists say trials haven't gone on for long enough, and that could backfire.
Kirill Dmitriev is the CEO of the Russian Direct Investment Fund, which is paying for research.